Gene expression dose-response of liver with a genotoxic and nongenotoxic carcinogen

Shawn D Seidel1, William T Stott, H Lynn Kan

  • 1Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, Michigan 48674, USA. sseidel2@dow.com

Insights

This study investigated how genotoxic and nongenotoxic carcinogens affect gene expression in rat livers. Results show distinct transcriptional responses, with higher doses potentially leading to adaptation or toxicity, altering gene expression patterns.

Area of Science:

  • Toxicology and Molecular Biology
  • Environmental Health Sciences

Background:

  • Chemical carcinogens induce tumors via genotoxic or nongenotoxic mechanisms.
  • Nongenotoxic tumorigenesis pathways are less understood than genotoxic ones.
  • Gene expression changes (transcriptome) offer insights into cellular responses to carcinogens.

Purpose of the Study:

  • To elucidate dose-response gene expression alterations in rat liver following exposure to a genotoxic (AAF) and a nongenotoxic (PB) carcinogen.
  • To compare the transcriptomic profiles induced by different modes of chemical carcinogenesis.
  • To investigate atypical dose-response relationships in gene expression.

Main Methods:

  • Male Big Blue Fischer 344 rats were administered varying doses of 2-acetylaminofluorene (AAF) or phenobarbital (PB) for 28 days.
  • Transcriptome analysis was conducted using the Clontech Rat Toxicology II microarray (465 genes).
  • Gene expression levels were quantified by hybridizing 32P-labeled cDNA targets.

Main Results:

  • AAF altered 14 genes (9 up, 5 down); PB altered 18 genes (10 up, 8 down).
  • Four genes showed common alterations (2 up, 2 down) between AAF and PB treatments.
  • Atypical dose-response patterns were observed, with higher doses sometimes resembling control levels, suggesting adaptation, toxicity, or remodeling.

Conclusions:

  • Both genotoxic and nongenotoxic carcinogens induce specific, yet partially overlapping, transcriptional changes in the liver.
  • Gene expression responses to toxic agents can exhibit complex dose-dependent patterns, deviating from simple linear relationships.
  • Understanding these transcriptional dynamics is crucial for characterizing chemical carcinogenesis and risk assessment.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...